Cancer Research3d
Abstract C033: Identifying and targeting prostate cancer therapy resistance mechanisms driven by the tumor microenvironment
1Fred Hutchinson Cancer Center, Seattle, WA.
Cancer Research3d
Abstract B006: Role of the BAF complex in pancreatic cancer-associated fibroblast function
Search for other works by this author on: ...
Cancer Research3d
Abstract PR015: Sepsis-induced inflammation alters natural killer cell-mediated surveillance of liver metastasis
Search for other works by this author on: ...
Cancer Research3d
Abstract IA007: Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs
Breast cancer is the second most common cancer globally. Most deaths from breast cancer are due to metastatic disease which often follows long periods of clinical dormancy. Understanding the ...
Cancer Research5d
American Association for Cancer Research
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
Cancer Research5d
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. *Corresponding Author: Jaleh Fallah, U.S. Center for Drug Evaluation and Research, Office of New ...
Cancer Research5d
BMS Hit with Renewed, Massive Lawsuit
Bristol Myers Squibb (BMS) faces a $6.7 billion lawsuit alleging that the company purposely delayed approval of Celgene-developed drugs to avoid paying Celgene shareholders owning contingent value ...
Cancer Research5d
The Intrauterine Device: How to Deploy This Strategy in the Molecular World?
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Medicine, Weill Cornell Medical College, New York, New York. *Corresponding Author: Claire F.
Cancer Research5d
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 9Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York ...
Cancer Research6d
The UBA1-STUB1 axis mediates cancer immune escape and resistance to checkpoint blockade
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license ...
Cancer Research6d
Merck Buys Bispecific Antibody for up to $3.3 Billion
Today, Merck announced that it will acquire LaNova Medicines’ PD-1/VEGF bispecific antibody, LM-299, for $588 million upfront plus financial awards that could reach $2.7 billion if certain development ...
Cancer Research6d
T Cells Home to Intracranial Metastases Via ICAM-1 + Peritumoral Venous Vessels
Major Finding: Antitumor T cells are recruited to intracranial metastases through ICAM-1 + peritumoral venous vessels (PVV). Concept: PVVs mediate T-cell recruitment and motility, which can be ...